Accéder au contenu
MilliporeSigma

Principaux documents

Voir toute la documentation

Passer à

EHU143181

Sigma-Aldrich

MISSION® esiRNA

targeting human CNOT8

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme

Sélectionner une taille de conditionnement

S604674-250MG
209,00 $

209,00 $

Veuillez contacter notre Service Clients pour connaître la disponibilité de ce produit.

Sélectionner une taille de conditionnement

Changer de vue
S604674-250MG
209,00 $

About This Item

Code UNSPSC :
41105324
Nomenclature NACRES :
NA.51

209,00 $

Veuillez contacter notre Service Clients pour connaître la disponibilité de ce produit.
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider

Description

Powered by Eupheria Biotech

Niveau de qualité

100

Gamme de produits

MISSION®

Forme

lyophilized powder

Séquence cible d'ADNc esiRNA

TGTGAAGTGTGGGCCAGTAATCTAGAAGAAGAGATGAGGAAGATCCGAGAAATCGTGCTCAGTTACAGTTATATTGCCATGGACACAGAATTTCCAGGTGTTGTGGTGCGACCAATTGGTGAATTTCGTAGTTCCATAGATTACCAATATCAGCTTCTGCGGTGCAATGTTGACCTTTTAAAAATTATCCAGCTGGGCCTTACATTCACAAATGAGAAGGGAGAGTATCCTTCTGGAATCAATACTTGGCAGTTCAATTTCAAATTTAACCTTACAGAGGACATGTACTCCCAGGATTCCATAGATCTCCTTGCTAACTCAGGACTACAGTTTCAGAAGCATGAAGAGGAAGGGATTGACACACTGCACTTTGCAGAGCTGCTTATGACATCAGGAGTGGTTCTCTGTGACAATGTCAAATGGCTTTCATTTCATAGTGGCTATGATTTTGGCTATATGGTAAAGTTGCTTACAGATTCTCGTTTGCCAGAAG

Numéro d'accès Ensembl | humain

ENSG00000155508

Numéro d'accès NCBI

NM_004779

Conditions d'expédition

ambient

Température de stockage

−20°C

Informations sur le gène

human ... CNOT8(9337), CNOT8(9337)

Catégories apparentées

Comparer avec des articles similaires

Voir la comparaison complète

Montrer les différences

1 of 4

Cet article
EHU017571EHU072681EHU102221
MISSION® esiRNA targeting human CNOT8

EHU143181

MISSION® esiRNA

MISSION® esiRNA targeting human CNOT6

EHU017571

MISSION® esiRNA

MISSION® esiRNA targeting human CNOT1

EHU072681

MISSION® esiRNA

MISSION® esiRNA targeting human DCLRE1A

EHU102221

MISSION® esiRNA

Gene Information

human ... CNOT8(9337), CNOT8(9337)

Gene Information

human ... CNOT6(57472), CNOT6(57472)

Gene Information

human ... CNOT1(23019), CNOT1(23019)

Gene Information

human ... DCLRE1A(9937), DCLRE1A(9937)

esiRNA cDNA target sequence

TGTGAAGTGTGGGCCAGTAATCTAGAAGAAGAGATGAGGAAGATCCGAGAAATCGTGCTCAGTTACAGTTATATTGCCATGGACACAGAATTTCCAGGTGTTGTGGTGCGACCAATTGGTGAATTTCGTAGTTCCATAGATTACCAATATCAGCTTCTGCGGTGCAATGTTGACCTTTTAAAAATTATCCAGCTGGGCCTTACATTCACAAATGAGAAGGGAGAGTATCCTTCTGGAATCAATACTTGGCAGTTCAATTTCAAATTTAACCTTACAGAGGACATGTACTCCCAGGATTCCATAGATCTCCTTGCTAACTCAGGACTACAGTTTCAGAAGCATGAAGAGGAAGGGATTGACACACTGCACTTTGCAGAGCTGCTTATGACATCAGGAGTGGTTCTCTGTGACAATGTCAAATGGCTTTCATTTCATAGTGGCTATGATTTTGGCTATATGGTAAAGTTGCTTACAGATTCTCGTTTGCCAGAAG

esiRNA cDNA target sequence

GCAAATTCTGAGGGGTCTGAAGCTATGCTGAACAGAGTCATGACAAAAGATAACATTGGGGTTGCAGTACTGCTAGAACTTCGGAAGGAATCGATTGAAATGCCGTCCGGAAAGCCACATCTTGGAACAGAAAAACAACTTATTCTTGTGGCTAACGCCCACATGCATTGGGACCCTGAATACTCTGATGTGAAGTTGGTACAAACTATGATGTTCCTCTCAGAAGTGAAGAACATTATTGATAAAGCCTCTCGCAACCTCAAATCCAGTGTTTTGGGAGAATTTGGAACTATTCCACTTGTGTTATGTGCAGATCTTAATTCTTTGCCAGACTCTGGTGTTGTAGAATATTTGAGCACAGGTGGAGTAGAAACAAATCACAAAGACTTTAAGGAGTTGAGGTATAATGAAAGTCTCACAAACTTCAGCTGTCATGGGAAGAATGGAACCACCAATGGAAGGATCACTCATGGTTTCAAGTTACAGAGTGCCTATGAGAGTGGCC

esiRNA cDNA target sequence

CAGAGGCAAACCAGCACTTTAGTAAAGAGATAGATGATGAAGCAAACAGCTATTTCCAGCGAATATATAATCATCCACCACATCCAACCATGTCTGTTGATGAGGTATTAGAAATGCTGCAGAGATTTAAAGACTCTACTATAAAGAGGGAACGAGAAGTATTTAACTGTATGCTAAGGAACTTGTTTGAAGAATATCGTTTTTTTCCCCAGTATCCTGATAAAGAGTTACATATAACAGCCTGCCTATTTGGTGGTATAATTGAGAAAGGACTGGTCACTTACATGGCACTAGGTCTGGCTCTACGATATGTTCTTGAAGCCTTACGCAAGCCTTTTGGATCCAAAATGTATTATTTCGGGATTGCTGCACTAGATAGATTTAAAAACAGATTGAAGGACTATCCCCA

esiRNA cDNA target sequence

CTTTGTCCAGGGACTGTGGTTGGATTTATGAATTATTTGGACGGTTGTCCACTTGAAAGAACTGACAGTAGCTTCATAACAATGTTACAAATCTCGTTCTAAGATTAAGCTGTTGAACCTATATTTGCCATTAGCGCTTAATTTTTGAAGTATTATTTTTATGAATCAAGCCCTGGAAAAGGACAAGATATTTGAATGAAATAGCACCCATAATGGAGAACTTCACAGTTGCTACTCCTGTGATAGGTTTATCTTAGTTTCATTGTGGTATAAATGGAATAGCAGGTGTTGTCAGGTACAAGGTTTGTAGCTTGCCAATATGTTCATTACCAACACTGCAGATTCCCATTGAGTTGG

product line

MISSION®

product line

MISSION®

product line

MISSION®

product line

MISSION®

Ensembl | human accession no.

ENSG00000155508

Ensembl | human accession no.

ENSG00000113300

Ensembl | human accession no.

ENSG00000125107

Ensembl | human accession no.

ENSG00000198924

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

form

lyophilized powder

form

lyophilized powder

form

lyophilized powder

form

lyophilized powder

Description générale

MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Informations légales

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Code de la classe de stockage

10 - Combustible liquids

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

  • Fiche des caractéristiques

    • Faites votre choix parmi les versions les plus récentes :

    Certificats d'analyse (COA)

    Lot/Batch Number

    It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

    Si vous avez besoin d'assistance, veuillez contacter Service Clients

    Déjà en possession de ce produit ?

    Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

    Consulter la Bibliothèque de documents

    Kai-Hui Sun et al.
    Journal of neurochemistry, 118(5), 902-914 (2011-06-15)
    Cyclin dependent kinase-5 (Cdk5) activity is deregulated in Alzheimer's disease (AD) and contributes to all three hallmarks: neurotoxic β-amyloid formation, neurofibrillary tangles, and neuronal death. However, the mechanism leading to Cdk5 deregulation remains controversial. Cdk5 deregulation in AD is usually
    Yusuke Yamamoto et al.
    Oncology reports, 30(4), 1687-1694 (2013-07-12)
    Glutathione S-transferases (GSTs) have been reported to be activated in several types of cancers, including esophageal squamous cell carcinoma (ESCC). The aim of the present study was to investigate whether GSTP1 protein expression is a useful predictor of the clinical
    D Pellacani et al.
    Cell death and differentiation, 21(5), 761-773 (2014-01-28)
    Prostate cancer (CaP) is mostly composed of luminal-like differentiated cells, but contains a small subpopulation of basal cells (including stem-like cells), which can proliferate and differentiate into luminal-like cells. In cancers, CpG island hypermethylation has been associated with gene downregulation
    Ko Omura et al.
    The Journal of toxicological sciences, 39(5), 785-794 (2014-09-23)
    We previously reported a toxicogenomics-based prediction model for hepatocarcinogens in which the expression patterns of signature genes following repeated doses of either genotoxic or non genotoxic compounds were similar. Based on the results of our prediction model, we hypothesized that
    Nicole C McKnight et al.
    PLoS genetics, 10(10), e1004626-e1004626 (2014-10-03)
    Deficiency of autophagy protein beclin 1 is implicated in tumorigenesis and neurodegenerative diseases, but the molecular mechanism remains elusive. Previous studies showed that Beclin 1 coordinates the assembly of multiple VPS34 complexes whose distinct phosphatidylinositol 3-kinase III (PI3K-III) lipid kinase

    Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

    Contacter notre Service technique